Comment
doi: 10.1136/annrheumdis-2018-214635.
Epub 2018 Nov 2.
Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment
Affiliations
- PMID: 30389689
- DOI: 10.1136/annrheumdis-2018-214635
Item in Clipboard
Comment
Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment
Ann Rheum Dis.
2019 Dec.
No abstract available
Keywords: DMARDs (synthetic); adult onset still's disease; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment' by Lee.Ann Rheum Dis. 2019 Dec;78(12):e134. doi: 10.1136/annrheumdis-2018-214653. Epub 2018 Nov 10. Ann Rheum Dis. 2019. PMID: 30415202 No abstract available.
Comment on
-
Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial.Ann Rheum Dis. 2018 Dec;77(12):1720-1729. doi: 10.1136/annrheumdis-2018-213920. Epub 2018 Oct 2. Ann Rheum Dis. 2018. PMID: 30279267 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
